Nanoparticle based on reactive Polypeptides
There are no basic technologies for nano-particles available, which are suitable for medical application. The present invention offers such a new technology, which is deal-ing with a bifid copolypeptide consisting of one hydrophilic polysarcosine and one hy-drophobic polycysteine part. The hydrophilic polysarcosine part prevents an unspecific binding on proteins, increases the solubility in the serum, and no immune reaction will be activated. Thus it is an ideal protection for encapsulated drugs.
The polycysteine part forms autonomous micelles in polar solvents, which are stabi-lized by cross linked disulphide bridges. The resulting micelles are stable in blood, in the cytosol, against glutathione and also survive endocytosis of antigen presenting cells or macrophages.
When the disulfide bonds were cleaved by metabolization, the copolymer loses its sta-bility and the active ingredient will be re-leased.
[Reference UMZ314]
Further information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50
Contact
Dr. Klaus Kobek
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Magnetic tornado is stirring up the haze at Jupiter’s poles
Unusual magnetically driven vortices may be generating Earth-size concentrations of hydrocarbon haze. While Jupiter’s Great Red Spot has been a constant feature of the planet for centuries, University of California,…
Cause of common cancer immunotherapy side effect s
New insights into how checkpoint inhibitors affect the immune system could improve cancer treatment. A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation…
New tool makes quick health, environmental monitoring possible
University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, environmental monitoring groups, or even you, the ability to quickly detect harmful and health-relevant substances…